PET-CT in brain disorders: The South African context

SA Journal of Radiology

Field Value
Title PET-CT in brain disorders: The South African context
Creator Doruyter, Alexander G.G. Parkes, Jeannette Carr, Jonathan Warwick, James M.
Subject nuclear medicine brain; positron emission tomography; F-18 fluorodeoxyglucose; F-18 fluoro-dihydroxyphenylalanine; dementia; brain tumour; Parkinson’s disease
Description Positron emission tomography combined with X-ray computed tomography (PET-CT) has an established role in the management of brain disorders, but may be underutilised in South Africa. Possible barriers to access include the limited number of PET-CT facilities and the lack of contemporary guidelines for the use of brain PET-CT in South Africa. The current review aims to highlight the evidence-based usage of brain Positron emission tomography (PET) in dementia, movement disorders, brain tumours, epilepsy, neuropsychiatric lupus, immune-mediated encephalitides, and brain infections. While being areas of research, there is currently no clinical role for the use of PET-CT in traumatic brain injury or in psychiatric or neurodevelopmental disorders. Strategies to expand the appropriate use of PET-CT in brain disorders are discussed in this article.
Publisher AOSIS
Date 2021-11-10
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Review
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajr.v25i1.2201
Source South African Journal of Radiology; Vol 25, No 1 (2021); 9 pages 2078-6778 1027-202X
Language eng
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
Coverage South Africa — —
Rights Copyright (c) 2021 Alexander Doruyter, Jeannette Parkes, Jonathan Carr, James Mathew Warwick